Fortsatt litt liv i leiren

Oslo, January 23, 2019. Bionor is pleased to announce that Proof of Mechanism is established for our 3rd vaccine candidate, Vacc-CRX. This product aims to prevent binding between gp120 V3 […]

https://bionorholding.com/vacc-crx-proof-of-mechanism-established/